Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1989-5-15
pubmed:abstractText
The relationships of plasma lipid and apolipoprotein (apo) concentrations to hepatic low-density lipoprotein (LDL) receptor activity were examined in 21 subjects (16 females, 5 males), who were undergoing laparotomy for non-neoplastic disease (cholecystectomy in 16). None had familial hypercholesterolemia, or renal, endocrine or hepatic disease. Ages were 37-77 years (mean, 58 years), plasma cholesterol concentrations 4.09-6.72 mmol/l (5.38) and plasma triacylglycerol concentrations 0.75-2.35 mmol/l (1.36). Receptor activity was quantified in vitro as the total saturable binding and EDTA-suppressible binding (representing apoB,E receptors) of 125I-labelled human LDL (15 micrograms protein/ml) by liver homogenate at 37 degrees C. There were no significant differences between men and women in 125I-labeled LDL binding. In the pooled data, EDTA-suppressible binding averaged 50 ng 125I-LDL protein/mg cell protein (S.D., 15). Total saturable binding averaged 2-fold greater (mean, 101 ng/mg; S.D., 32). Plasma cholesterol, LDL cholesterol and apoB concentrations were negative functions of both EDTA-suppressible binding and total saturable binding, but the correlations with EDTA-suppressible binding were stronger (cholesterol: r = -0.59, P less than 0.01; LDL cholesterol: r = -0.48, P less than 0.05; apoB: r = -0.61, P less than 0.01). Plasma triacylglycerol, high-density lipoprotein cholesterol and apoA-I concentrations were not related to either measure of receptor activity. These results provide evidence that the activity of apoB,E receptors in the liver is a major determinant of the plasma LDL concentration in middle-aged and elderly humans.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-I, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins A, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins B, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Edetic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes, http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0006-3002
pubmed:author
pubmed:issnType
Print
pubmed:day
3
pubmed:volume
1002
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
245-55
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:2495023-Adult, pubmed-meshheading:2495023-Aged, pubmed-meshheading:2495023-Animals, pubmed-meshheading:2495023-Apolipoprotein A-I, pubmed-meshheading:2495023-Apolipoproteins, pubmed-meshheading:2495023-Apolipoproteins A, pubmed-meshheading:2495023-Apolipoproteins B, pubmed-meshheading:2495023-Cattle, pubmed-meshheading:2495023-Cholesterol, pubmed-meshheading:2495023-Cholesterol, HDL, pubmed-meshheading:2495023-Cholesterol, LDL, pubmed-meshheading:2495023-Edetic Acid, pubmed-meshheading:2495023-Female, pubmed-meshheading:2495023-Humans, pubmed-meshheading:2495023-Iodine Radioisotopes, pubmed-meshheading:2495023-Kinetics, pubmed-meshheading:2495023-Lipids, pubmed-meshheading:2495023-Lipoproteins, LDL, pubmed-meshheading:2495023-Liver, pubmed-meshheading:2495023-Male, pubmed-meshheading:2495023-Middle Aged, pubmed-meshheading:2495023-Rabbits, pubmed-meshheading:2495023-Rats, pubmed-meshheading:2495023-Receptors, LDL, pubmed-meshheading:2495023-Triglycerides
pubmed:year
1989
pubmed:articleTitle
Human hepatic low-density lipoprotein receptors: associations of receptor activities in vitro with plasma lipid and apolipoprotein concentrations in vivo.
pubmed:affiliation
Department of Chemical Pathology and Metabolic Disorders, St. Thomas' Campus, United Medical School of Guy's Hospital, London U.K.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't